Neuroinflammatory processes are important in neurodegenerative diseases: An hypothesis to explain the increased formation of reactive oxygen and nitrogen species as major factors involved in neurodegenerative disease development

Free Radical Biology and Medicine

Volumn 26, Issue 9-10, 1999, Pages 1346-1355

  Floyd, Robert A ^a  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; NITROGEN DERIVATIVE; REACTIVE OXYGEN METABOLITE;

ALZHEIMER DISEASE; ARTICLE; BRAIN INFARCTION; BRAIN INJURY; CYTOKINE PRODUCTION; DEGENERATIVE DISEASE; ENCEPHALITIS; HUMAN; INFLAMMATION; PRIORITY JOURNAL;

ALZHEIMER DISEASE; ANIMALS; BRAIN; CEREBRAL INFARCTION; CRANIOCEREBRAL TRAUMA; HUMANS; INFLAMMATION; MICROCIRCULATION; MODELS, NEUROLOGICAL; NERVE DEGENERATION; NEURODEGENERATIVE DISEASES; NITROGEN; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; RISK FACTORS;

EID: 0033021002     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(98)00293-7     Document Type: Article

References (110)

1. Tanner C.M., Langston J.W. Do environmental toxins cause Parkinson's disease? A critical review. Neurology. 40:1990;17-31.
2. Spencer P.S., Nunn P.B., Hugon J., Ludolph A.C., Ross S.M., Roy D.N., Robertson R.C. Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin. Science. 237:1987;517-522.
3. Colton C.A., Gilbert D.L. Production of superoxide anions by a CNS macrophage, the microglia. Fed. Eur. Biochem. Soc. 223:1987;284-288.
4. Colton C.A., Yao J., Gilbert D., Oster-Granite M.L. Enhanced production of superoxide anion by microglia from trisomy 16 mice. Brain Res. 519:1990;236-242.
5. Vandenabeele P., Fiers W. Is amyloidogenesis during Alzheimer's disease due to an IL-1-/IL-6-mediated 'acute phase response' in the brain? Immunol. Today. 12:1991;217-219.
6. 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients. Lab. Invest. 66:1992;223-230.
7. Rothwell N.J., Relton J.K. Involvement of cytokines in acute neurodegeneration in the CNS. Neurosci. Biobehav. Rev. 17:1993;217-227.
8. McGeer, P. L.; McGeer, E.; Rogers, J.; Sibley, J. Anti-inflammatory drugs and Alzheimer disease. Lancet 335(8696):1037; 1990.
9. Tooyama I., Kimura H., Akiyama H., McGeer P.L. Reactive microglia express class I and class II major histocompatibility complex antigens in Alzheimer's disease. Brain Res. 523:1990;273-280.
10. Rogers J., Cooper N.R., Webster S., Schultz J., McGeer P.L., Styren S.D., Civin W.H., Brachova L., Bradt B., Ward P., Lieberburg I. Complement activation by β-amyloid in Alzheimer disease. Proc. Natl. Acad. Sci. USA. 89:1992;10016-10020.
11. Benveniste E.N. Inflammatory cytokines within the central nervous system Sources, function, and mechanism of action . Am. J. Physiol. 263:1992;C1-C16.
12. Merrill J.E. Tumor necrosis factor alpha, interleukin 1 and related cytokines in brain development Normal and pathological . Dev. Neurosci. 14:1992;1-10.
13. Wong M.-L., Bongiorno P.B., Rettori V., McCann S.M., Licinio J. Interleukin (IL) 1β, IL-1 receptor antagonist, IL-10, and IL-13 gene expression in the central nervous system and anterior pituitary during systemic inflammation Pathophysiological implications . Proc. Natl. Acad. Sci. USA. 94:1997;227-232.
14. Rogers J., O'Barr S. Inflammatory mediators in Alzheimer's disease. Wasco W., Tanzi R.E. Molecular mechanisms of dementia. 1997;177-198 Humana Press, Totowa, New Jersey.
15. Benveniste, E. N. Cytokine circuits in brain - implications for AIDS dementia complex. In: Price, R. W.; Perry, S. W., eds. HIV, AIDS and the brain. New York: Raven Press; 1994:71-88.
16. Merrill J.E., Chen I.S.Y. HIV-1, macrophages, glial cells, and cytokines in AIDS nervous system disease. FASEB J. 5:1991;2391-2397.
17. Benveniste E.N., Benos D.J. TNF-α- and IFN-γ mediated signal transduction pathways Effects on glial cell gene expression and function . FASEB J. 9:1995;1577-1584.
18. Yan S.D., Zhu H., Fu J., Yan S.F., Roher A., Tourtellotte W.W., Rajavashisth T., Chen X., Godman G.C., Stern D., Schmidt A.M. Amyloid-β peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor A proinflammatory pathway in Alzheimer disease . Proc. Natl. Acad. Sci. USA. 94:1997;5296-5301.
19. Sheng J.G., Ito K., Skinner R.D., Mrak R.E., Rovnaghi C.R., Van Eldik L.J., Griffin W.S.T. In vivo an in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis. Neurobiol. Aging. 17:1996;761-766.
20. Bell M.J., Kochanek P.M., Doughty L.A., Carcillo J.A., Adelson P.D., Clark R.S.B., Wisniewski S.R., Whalen M.J., DeKosky S.T. Interleukin-6 and interleukin-10 in cerebrospinal fluid after severe traumatic brain injury in children. J. Neurotrauma. 14:1997;451-457.
21. McGeer P.L., Walker D.G., Akiyama H., Kawamata T., Guan A.L., Parker C.J., Okada N., McGeer E.G. Detection of the membrane inhibitor of reactive lysis (CD59) in diseased neurons of Alzheimer brain. Brain Res. 544:1991;315-319.
22. Choi-Miura N.-H., Ihara Y., Fukuchi K., Takeda M., Nakano Y., Tobe T., Tomita M. SP-40, 40 is a constituent of Alzheimer's amyloid. Acta. Neuropathol. 83:1992;260-264.
23. Cotman, C. W.; Tenner, A. J.; Cummings, B. J. β-Amyloid converts an acute phase injury response to chronic injury responses. Neurobiol Aging17:723-731; 1996.
24. Snowdon D.A., Greiner L.H., Mortimer J.A., Riley K.P., Greiner P.A., Markesbery W.R. Brain infarction and the clinical expression of Alzheimer disease the Nun study. JAMA. 277:1997;813-817.
25. Wakita H., Tomimoto H., Akiguchi I., Ohnishi K., Nakamura S., Kimura J. Regional accumulation of amyloid β/A4 protein precursor in the gerbil brain following transient cerebral ischemia. Neurosci. Lett. 146:1992;135-138.
26. Rudelli R., Strom J.O., Welch P.T., Ambler M.W. Posttraumatic premature Alzheimer's disease neuropathologic findings and pathogenetic considerations. Arch. Neurol. 39:1982;570-575.
27. French L.R., Schuman L.M., Mortimer J.A., Hutton J.T., Boatman R.A., Christians B. A case-control study of dementia of the Alzheimer type. Am. J. Epidemiol. 121:1985;414-421.
28. Mortimer J.A., French L.R., Hutton J.T., Schuman L.M. Head injury as a risk factor for Alzheimer's disease. Neurology. 35:1985;264-267.
29. Markesbery W.R. Oxidative stress hypothesis in Alzheimer's disease. Free Radic. Biol. Med. 23:1997;134-147.
30. Kalaria R.N. Cerebral microvasculature and immunological factors in Alzheimer's disease. Clin. Neurosci. 1:1993;204-211.
31. Grammas P., Liu G.-J., Wood K., Floyd R.A. Anoxia/reoxygenation induces hydroxyl free radical formation in brain microvessels. Free Radic. Biol. Med. 14:1993;553-557.
32. Nogawa S., Zhang F., Ross M.E., Iadecola C. Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage. J. Neurosci. 17:1997;2746-2755.
33. Iadecola C., Zhang F., Casey R., Clark H.B., Ross M.E. Inducible nitric oxide synthase gene expression in vascular cells after transient focal cerebral ischemia. Stroke. 27:1996;1373-1380.
34. Dorheim M.-A., Tracey W.R., Pollock J.S., Grammas P. Nitric oxide synthase activity is elevated in brain microvessels in Alzheimer's disease. Biochem. Biophys. Res. Commun. 205:1994;659-665.
35. Grammas, P.; Liu, G.-J.; Kumar, M.; Floyd, R. Protein oxidation in cerebral microvessels in Alzheimer's disease. Neurobiol. Aging15:S124 (Abstract); 1994.
36. Floyd R.A., Carney J.M. Age influence on oxidative events during brain ischemia/reperfusion. Arch. Gerontol. Geriatr. 12:1991;155-177.
37. Floyd R.A., Carney J.M. Free radical damage to protein and DNA Mechanisms involved and relevant observations on brain undergoing oxidative stress . Ann. Neurol. 32:1992;S22-S27.
38. Floyd R.A. Role of oxygen free radicals in carcinogenesis and brain ischemia. FASEB J. 4:1990;2587-2597.
39. Volicer L., Crino P.B. Involvement of free radicals in dementia of the Alzheimer type A hypothesis . Neurobiol. Aging. 11:1990;567-571.
40. Smith M.A., Perry G. Free radical damage, iron, and Alzheimer's disease. J. Neurol. Sci. 134:(Suppl.):1995;92-94.
41. Smith M.A., Sayre L.M., Monnier V.M., Perry G. Radical Ageing in Alzheimer's disease. Trends. Neurosci. 18:1995;172-176.
42. Smith M.A., Rudnicka-Nawrot M., Richey P.L., Praprotnik D., Mulvihill P., Miller C.A., Sayre L.M., Perry G. Carbonyl-related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer's disease. J. Neurochem. 64:1995;2660-2666.
43. Yan S.D., Yan S.F., Chen X., Fu J., Chen M., Kuppusamy P., Smith M.A., Perry G., Godman G.C., Nawroth P., Zweier J.L., Stern D. Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid β-peptide. Nature Med. 1:1995;693-699.
44. Smith M.A., Perry G., Richey P.L., Sayre L.M., Anderson V.E., Beal M.F., Kowall N. Oxidative damage in Alzheimer's. Nature. 382:1996;120-121.
45. Dexter D.T., Carter C.J., Wells F.R., Javoy-Agid F., Agid Y., Lees A., Jenner P., Marsden C.D. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J. Neurochem. 52:1989;381-389.
46. Fahn S., Cohen G. The oxidant stress hypothesis in Parkinson's disease Evidence supporting it . Ann. Neurol. 32:1992;804-812.
47. McNamara J.O., Fridovich I. Did radicals strike Lou Gehrig? Nature. 362:1993;20-21.
48. Willmore L.J., Sypert G.W., Munson J.B., Hurd R.W. Chronic focal epileptiform discharges induced by injection of iron into rat and cat cortex. Science. 200:1978;1501-1503.
49. Willmore L.J., Sypert G.W., Munson J.B. Recurrent seizures induced by cortical iron injection a model of posttraumatic epilepsy . Ann. Neurol. 4:1978;329-336.
50. Willmore L.J., Rubin J.J. The effect of tocopherol and dimethyl sulfoxide on focal edema and lipid peroxidation induced by isocortical injection of ferrous chloride. Brain Res. 296:1984;389-392.
51. Cheng Y., Sun A.Y. Oxidative mechanisms involved in Kainate-induced cytotoxicity in cortical neurons. Neurochem. Res. 19:1994;1557-1564.
52. Bruce A.J., Baudry M. Oxygen free radicals in rat limbic structures after kainate-induced seizures. Free Radic. Biol. Med. 18:1995;993-1002.
53. Corral-Debrinski M., Horton T., Lott M.T., Shoffner J.M., Beal M.F., Wallace D.C. Mitochondrial DNA deletions in human brain Regional variability and increase with advanced age . Nature Genetics. 2:1992;324-329.
54. Mecocci P., MacGarvey U., Kaufman A.E., Koontz D., Shoffner J.M., Wallace D.C., Beal M.F. Oxitative damage to mitochondrial DNA shows marked age-dependent increases in human brain. Ann. Neurol. 34:1993;609-616.
55. Beal M.F. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann. Neurol. 38:1995;357-366.
56. Cao W., Carney J.M., Duchon A., Floyd R.A., Chevion M. Oxygen free radical involvement in ischemia and reperfusion injury to brain. Neurosci. Lett. 88:1988;233-238.
57. Braughler J.M., Hall E.D. Central nervous system trauma and stroke. I. Biochemical considerations for oxygen radical formation and lipid peroxidation. Free Radic. Biol. Med. 6:1989;289-301.
58. Hall E.D., Braughler J.M. Central nervous system trauma and stroke. II. Physiological and pharmacological evidence for involvement of oxygen radicals and lipid peroxidation. Free Radic. Biol. Med. 6:1989;303-313.
59. Hall E.D. The role of oxygen radicals in traumatic injury Clinical implications . J. Emerg. Med. 11:1993;31-36.
60. Hall E.D., Andrus P.K., Yonkers P.A. Brain hydroxyl radical generation in acute experimental head injury. J. Neurochem. 60:1993;588-594.
61. Hall E.D., Andrus P.K., Althaus J.S., VonVoigtlander P.F. Hydroxyl radical production and lipid peroxidation parallels selective post-ischemic vulnerability in gerbil brain. J. Neurosci. Res. 34:1993;107-112.
62. Smith C.D., Carney J.M., Starke-Reed P.E., Oliver C.N., Stadtman E.R., Floyd R.A., Markesbery W.R. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 88:1991;10540-10543.
63. Schulz J.B., Henshaw D.R., Siwek D., Jenkins B.G., Ferrante R.J., Cipolloni P.B., Kowall N.W., Rosen B.R., Beal M.F. Involvement of free radicals in excitotoxicity in vivo. J. Neurochem. 64:1995;2239-2247.
64. Zhang J.-R., Andrus P.K., Hall E.D. Age-related regional changes in hydroxyl radical stress and antioxidants in gerbil brain. J. Neurochem. 61:1993;1640-1647.
65. Bowling A.C., Beal M.F. Bioenergetic and oxidative stress in neurodegenerative diseases. Life Sci. 56:1995;1151-1171.
66. Iadecola C. Bright and dark sides of nitric oxide in ischemic brain injury. Trends. Neurosci. 20:1997;132-139.
67. Iadecola C., Zhang F., Xu S., Casey R., Ross M.E. Inducible nitric oxide synthase gene expression in brain following cerebral ischemia. J. Cereb. Blood Flow Metab. 15:1995;378-384.
68. Iadecola C., Zhang F., Xu X. Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage. Am. J. Physiol. 268:1995;R286-R292.
69. Carney J.M., Kindy M.S., Smith C.D., Wood K., Tatsuno T., Wu J.F., Landrum W.R., Floyd R.A. Gene expression and functional changes after acute ischemia Age-related differences in outcome and mechanisms . Hartmann A., Yatsu F., Kuschinsky W. Cerebral ischemia and basic mechanisms. 1994;301-311 Springer-Verlag, Berlin, Heidelberg.
70. McClain C.J., Cohen D., Ott L., Dinarello C.A., Young B. Ventricular fluid interleukin-1 activity in patients with head injury. J. Lab. Clin. Med. 110:1987;48-54.
71. Floyd R.A. Protective action of nitrone-based free radical traps against oxidative damage to the central nervous system. Adv. Pharmacol. 38:1997;361-378.
72. Funahashi T., Floyd R.A., Carney J.M. Age effect on brain pH during ischemia/reperfusion and pH influence on peroxidation. Neurobiol. Aging. 15:1994;161-167.
73. Irani K., Xia Y., Zweier J.L., Sollott S.J., Der C.J., Fearon E.R., Sundaresan M., Finkel T., Goldschmidt-Clermont P.J. Mitogenic signaling mediated by oxidants in ras-transformed fibroblasts. Science. 275:1997;1649-1652.
74. Hensley K., Maidt M.L., Pye Q.N., Stewart C.A., Wack M., Tabatabaie T., Floyd R.A. Quantitation of protein-bound 3-nitrotyrosine and 3,4-dihydroxyphenylalanine by high performance liquid chromatography with electrochemical array detection. Anal. Biochem. 251:1997;187-195.
75. Schreck R., Rieber P., Baeuerle P.A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J. 10:1991;2247-2258.
76. 2 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells AP-1 as secondary antioxidant-responsive factor . EMBO J. 12:1993;2005-2015.
77. Hennet T., Richter C., Peterhans E. Tumour necrosis factor-α induces superoxide anion generation in mitochondria of L929 cells. Biochem. J. 289:1993;587-592.
78. Schulze-Osthoff K., Beyaert R., Vandevoorde V., Haegeman G., Fiers W. Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF. EMBO J. 12:1993;3095-3104.
79. Goossens V., Grooten J., De Vos K., Fiers W. Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity. Proc. Natl. Acad. Sci. USA. 92:1995;8115-8119.
80. Carini R., Leonarduzzi G., Camandola S., Musso T., Varesio L., Baeuerle P.A., Poli G. Activation of human immunodeficiency virus long terminal repeat by arachidonic acid. Free Radic. Biol. Med. 22:1997;195-199.
81. Garcia-Ruiz C., Colell A., Mari M., Morales A., Fernandez-Checa J. Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species. J. Biol. Chem. 272:1997;11369-11377.
82. Henkel T., Machleidt T., Alkalay I., Kronke M., Ben-Neriah Y., Baeuerle P.A. Rapid proteolysis of IκB-α is necessary for activation of transcription factor NF-κB. Nature. 365:1993;182-185.
83. McMillian M., Kong L.-Y., Sawin S.M., Wilson B., Das K., Hudson P., Hong J.-S., Bing G. Selective killing of cholinergic neurons by microglial activation in basal forebrain mixed neuronal/glial cultures. Biochem. Biophys. Res. Commun. 215:1995;572-577.
84. Floyd R.A., Stewart C.A., Tabatabaie T., Hensley K., Quentin P., Liu P.K. Apoptosis in brain cells-role in neurodegeneration. Christen Y., Doly M., Droy-Lefaix M.-T. Les Seminaires Ophtalmologiques d'IPSEN, "Retine, apoptose et cytokines." 1997;17-30 Irvinn, Paris.
85. Galea E., Feinstein D.L., Reis D.J. Induction of calcium-independent nitric oxide synthase activity in primary rat glial cultures. Proc. Natl. Acad. Sci. USA. 89:1992;10945-10949.
86. Dawson V.L., Dawson T.M., Bartley D.A., Uhl G.R., Snyder S.H. Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J. Neurosci. 13:1993;2651-2661.
87. Lowenstein C.J., Alley E.W., Raval P., Snowman A.M., Snyder S.H., Russell S.W., Murphy W.J. Macrophage nitric oxide synthase gene Two upstream regions medite induction by interferon γ and lipopolysaccharide . Proc. Natl. Acad. Sci. USA. 90:1993;9730-9734.
88. Kamijo R., Harada H., Matsuyama T., Bosland M., Gerecitano J., Shapiro D., Le J., Koh S.I., Kimura T., Green S.J., Mak T.W., Taniguchi T., Vilcek J. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science. 263:1994;1612-1615.
89. Evans T.J., Buttery L.D.K., Carpenter A., Springall D.R., Polak J.M., Cohen J. Cytokine-treated human neutrophils contain inducible nitric oxide synthase that produces nitration of ingested bacteria. Proc. Natl. Acad. Sci. USA. 93:1996;9553-9558.
90. Eissa N.T., Strauss A.J., Haggerty C.M., Choo E.K., Chu S.C., Moss J. Alternative splicing of human inducible nitric-oxide synthase mRNA. J. Biol. Chem. 271:1996;27184-27187.
91. Bonfoco E., Krainc D., Ankarcrona M., Nicotera P., Lipton S.A. Apoptosis and necrosis Two distinct events induced, respectively, by mild intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures . Proc. Natl. Acad. Sci. USA. 92:1995;7162-7166.
92. Koppenol W.H., Moreno J.J., Pryor W.A., Ischiropoulos H., Beckman J.S. Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide. Chem. Res. Toxicol. 5:1992;834-842.
93. Beckman J.S., Crow J.P. Pathological implications of nitric oxide, superoxide and peroxynitrite formation. Biochem. Soc. Trans. 21:1993;330-334.
94. Beckman J.S., Ischiropoulos H., Zhu L., van der Woerd M., Smith C., Chen J., Harrison J., Martin J.C., Tsai M. Kinetics of superoxide dismutase- and iron-catalyzed nitration of phenolics by peroxynitrite. Arch. Biochem. Biophys. 298:1992;438-445.
95. Ischiropoulos H., Zhu L., Chen J., Tsai M., Martin J.C., Smith C.D., Beckman J.S. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch. Biochem. Biophys. 298:1992;431-437.
96. Smith M.A., Harris P.L.R., Sayre L.M., Beckman J.S., Perry G. Widespread peroxynitrite-mediated damage in Alzheimer's disease. J. Neurosci. 17:1997;2653-2657.
97. Beal M.F., Brown R.H. Jr, Kowall N.W., Matthews R.T., Browne S.E., Ferrante R.J. Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Ann. Neurol. 42:1997;644-654.
98. Bolanos J.P., Almeida A., Stewart V., Peuchen S., Land J.M., Clark J.B., Heales S.J.R. Nitric oxide-mediated mitochondrial damage in the brain mechanisms and implications for neurodegenerative diseases . J. Neurochem. 68:1997;2227-2240.
99. Qureshi G.A., Baig S., Bednar I., Sodersten P., Forsberg G., Siden A. Increased cerebrospinal fluid concentration of nitrite in Parkinson's disease. Neuroreport. 6:1995;1642-1644.
100. Kuiper M.A., Visser J.J., Bergmans P.L.M., Scheltens P., Wolters E.C. Decreased cerebrospinal fluid nitrate levels in Parkinson's disease, Alzheimer's disease and multiple system atrophy patients. J. Neurol. Sci. 121:1994;46-49.
101. Wack, M. F.; Radike, J. K.; Maidt, L.; Hensley, K.; Floyd, R. A. Nitric oxide oxidative damage products in cerebral, spinal fluid of patients with AIDs and bacterial meningitis. Soc. Neurosci. Abst.23:326.6 abstr. (1997).
102. Adamson D.C., Wildemann B., Sasaki M., Glass J.D., McArthur J.C., Christov V.I., Dawson T.M., Dawson V.L. Immunologic NO synthase Elevation in severe AIDS dementia and induction by HIV-1 gp41 . Science. 274:1996;1917-1921.
103. Tabatabaie T., Stewart C., Pye Q., Kotake Y., Floyd R.A. In vivo trapping of nitric oxide in the brain of neonatal rats treated with the HIV-1 envelope protein gp 120 Protective effects of α-phenyl-tert-butylnitrone . Biochem. Biophys. Res. Commun. 221:1996;386-390.
104. Dawson V.L., Dawson T.M., Uhl G. R and Snyder, S. H. Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures. Proc. Natl. Acad. Sci. USA. 90:1993;3256-3259.
105. Breitner J.C.S., Gau B.A., Welsh K.A., Plassman B.L., McDonald W.M., Helms M.J., Anthony J.C. Inverse association of anti-inflammatory treatments and Alzheimer's disease Initial results of a co-twin control study . Neurology. 44:1994;227-232.
106. Breitner J.C.S., Welsh K.A., Helms M.J., Gaskell P.C., Gau B.A., Roses A.D., Pericak-Vance M.A., Saunders A.M. Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs. Neurobiol. Aging. 16:1995;523-530.
107. Pereira H.A., Kumar P., Grammas P. Expression of CAP37, a novel inflammatory mediator, in Alzheimer's disease. Neurobiol. Aging. 17:1996;753-759.
108. Rogers J., Webster S., Lue L.-F., Brachova L., Civin W.H., Emmerling M., Shivers B., Walker D., McGreer P. Inflammation and Alzheimer's disease pathogenesis. Neurobiol. Aging. 17:1996;681-686.
109. Floyd R.A., Carney J.M. Nitrone radical traps protect in experimental neurodegenerative diseases. Chapman C.A., Olanow C.W., Jenner P., Youssim M. Neuroprotective approaches to the treatment of Parkinson's disease and other neurodegenerative disorders. 1996;69-90 Academic Press Ltd, London.
110. DiPatre P.L., Gelman B.B. Microglial cell activation in aging and Alzheimer disease partial linkage with neurofibrillary tangle burden in hippocampus . J. Neuropathol. Exp. Neurol. 56:1997;143-149.